Zhongzhi Pharmaceutical Holdings Balance Sheet Health
Financial Health criteria checks 5/6
Zhongzhi Pharmaceutical Holdings has a total shareholder equity of CN¥1.1B and total debt of CN¥74.6M, which brings its debt-to-equity ratio to 6.7%. Its total assets and total liabilities are CN¥2.0B and CN¥850.0M respectively. Zhongzhi Pharmaceutical Holdings's EBIT is CN¥107.6M making its interest coverage ratio 42.8. It has cash and short-term investments of CN¥198.9M.
Key information
6.7%
Debt to equity ratio
CN¥74.57m
Debt
| Interest coverage ratio | 42.8x |
| Cash | CN¥198.92m |
| Equity | CN¥1.11b |
| Total liabilities | CN¥850.02m |
| Total assets | CN¥1.96b |
Recent financial health updates
These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
May 24
Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?
Aug 26Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet
Apr 28These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
Jun 11Recent updates
Little Excitement Around Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Earnings As Shares Take 26% Pounding
Aug 22Calculating The Intrinsic Value Of Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Jun 19Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation
May 10Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03
May 05Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03
Apr 21Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares
Feb 01These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
May 24Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?
Aug 26Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet
Apr 28These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
Jun 11Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)
May 06Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues
Apr 21Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?
Mar 29The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More
Mar 05Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?
Feb 15
What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?
Jan 14Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?
Dec 27If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late
Dec 14Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?
Nov 30Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?
Nov 17Financial Position Analysis
Short Term Liabilities: 3737's short term assets (CN¥976.9M) exceed its short term liabilities (CN¥700.2M).
Long Term Liabilities: 3737's short term assets (CN¥976.9M) exceed its long term liabilities (CN¥149.8M).
Debt to Equity History and Analysis
Debt Level: 3737 has more cash than its total debt.
Reducing Debt: 3737's debt to equity ratio has increased from 0% to 6.7% over the past 5 years.
Debt Coverage: 3737's debt is well covered by operating cash flow (226.2%).
Interest Coverage: 3737's interest payments on its debt are well covered by EBIT (42.8x coverage).